Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammation and aging: signaling pathways and intervention therapies. | Signal Transduct Target Ther | 2023 | 37291105 | PubTator, text mining | PubMed |
| The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects. | Front Pharmacol | 2023 | 37284316 | PubTator, text mining | PubMed |
| An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer. | Oncologist | 2023 | 37279952 | PubTator, text mining | PubMed |
| Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer. | Pharmaceuticals (Basel) | 2023 | 37259447 | PubTator, text mining | PubMed |
| Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. | Pharmaceuticals (Basel) | 2023 | 37259344 | PubTator, text mining | PubMed |
| Global analysis of contact-dependent human-to-mouse intercellular mRNA and lncRNA transfer in cell culture. | Elife | 2023 | 37249209 | PubTator, text mining | PubMed |
| β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects. | Adv Nutr | 2023 | 37247842 | PubTator, text mining | PubMed |
| S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. | Pharmaceuticals (Basel) | 2023 | 37242532 | PubTator, text mining | PubMed |
| Bioinformatics Identification of Regulatory Genes and Mechanism Related to Hypoxia-Induced PD-L1 Inhibitor Resistance in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 37240068 | PubTator, text mining | PubMed |
| Decoding protein methylation function with thermal stability analysis. | Nat Commun | 2023 | 37230995 | PubTator, text mining | PubMed |
| Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression. | PLoS Comput Biol | 2023 | 37228122 | PubTator, text mining | PubMed |
| Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma. | J Clin Invest | 2023 | 37219943 | PubTator, text mining | PubMed |
| Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex. | Aging (Albany NY) | 2023 | 37219418 | PubTator, text mining | PubMed |
| The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma. | Front Immunol | 2023 | 37207200 | PubTator, text mining | PubMed |
| Stable kinetochore-microtubule attachment requires loop-dependent Ndc80-Ndc80 binding. | EMBO J | 2023 | 37203876 | PubTator, text mining | PubMed |
| The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response. | Front Oncol | 2023 | 37197417 | PubTator, text mining | PubMed |
| [Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 37183646 | PubTator, text mining | PubMed |
| Molecular and biologic biomarkers of Ewing sarcoma: A systematic review. | J Bone Oncol | 2023 | 37180735 | PubTator, text mining | PubMed |
| The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC. | Front Immunol | 2023 | 37180150 | PubTator, text mining | PubMed |
| Immunological role and prognostic value of the SKA family in pan-cancer analysis. | Front Immunol | 2023 | 37180139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=20